Table 2.
Primers Used in The Present Study.
Primers | Sequence | Reference | Genbank accession no. |
---|---|---|---|
Abca1 |
5′GCAGATCAAGCATCCCAACT 3′ 3′CCAGAGAATGTTTCATTGTCCA 5′ |
48 | NM_013454.3 |
Abcb1a |
5′GGGCATTTACTTCAAACTTGT 3′ 3′TTTACAAGCTTCATTTCTCAA 5′ |
48 | NM_011076.3 |
Abcb1b |
5′AAGCCAGTATTCTGCCAAGCAT 3′ 3′CTCCAGACTGCTGTTGCTGATG 5′ |
48 | NM_011075.2 |
Abcb4 |
5′GAAGGGATCTACTTCAGACTCGTT 3′ 3′TCAACTTCAAATTCTTCTGACAGG 5′ |
48 | NM_008830.2 |
Abcb9 |
5′GTGTATTGTTGGATGGCAAGC 3′ 3′GGAGATGTTGTCTGTGATGGAG 5′ |
49 | NM_019875.2 |
Abcc2 |
5′TAATGAGGCGCCGTGGGTGAC 3′ 3′GTCCTGCCCACCACACCGAC 5′ |
50 | NM_013806.2 |
Abcc5 |
5′AAATGTATGCCTGGGTCAAAGC3′ 3′TGGCGATCACTACCACAATAGG5′ |
* | NM_013790.2 |
Abcg2 |
5′TGCCAGGCGCTCATTTAAAAACTTGC3′ 3′GCATTCCAGCGGCATCATATTTCAGA 5′ |
50 | NM_011920.3 |
Abcf2 |
5′TGTCCACATTATCAACCTCTCCC 3′ 3′TCACGTTTCCCAATAGCCGAG 5′ |
* | NM_013853.2 |
Il6 |
5′GAGGATACCACTCCCAACAGACC 3′ 3′AAGTGCATCATCGTTGTTCATACA 5′ |
49 | NM_031168.2 |
Cxcl1 |
5′ACCCGCTCGCTTCTCTGT 3′ 3′AAGGGAGCTTCAGGGTCAAG 5′ |
49 | NM_008176.3 |
Ccl2 |
5′GGTCCCTGTCATGCTTCTGG 3′ 3′CCTGCTGCTGGTGATCCTCT 5′ |
51 | NM_011333.3 |
Gapdh |
5′TGTGTCCGTCGTGGATCTGA 3′ 3′TTGCTGTTGAAGTCGCAGGAG 5′ |
52 | NM_001289726.1 |
Ywhaz |
5′ GAAAAGTTCTTGATCCCCAATGC 3′ 5′ TGTGACTGGTCCACAATTCCTT 3′ |
* | NM_011740.3 |
β-actin |
5′ AAATCTGGCACCACACCTTC 3′ 5′ GGGGTGTTGAAGGTCTCAAA 3′ |
53 | NM_007393.5 |
Ppib |
5′ GAGACTTCACCAGGGG 3′ 5′ CTGTCTGTCTTGGTGCTCTCC 3′ |
* | NM_011149.2 |
Rplp0 |
5′ GGCCCTGCACTCTCGCTTTC 3′ 5′ TGCCAGGACGCGCTTGT 3′ |
* | NM_007475.5 |
*Gene specific primers were designed with primer-BLAST (http://www.ncbi.nlm.gov/tools/primer-blast).